120 related articles for article (PubMed ID: 9692524)
1. New insights into the therapy and pathophysiology of patients with obstructive sleep apnoea syndrome.
Chin K; Ohi M
Respirology; 1998 Jun; 3(2):139-43. PubMed ID: 9692524
[TBL] [Abstract][Full Text] [Related]
2. Heat shock protein 72 level decreases during sleep in patients with obstructive sleep apnea syndrome.
Noguchi T; Chin K; Ohi M; Kita H; Otsuka N; Tsuboi T; Satoh M; Nakai A; Kuno K; Nagata K
Am J Respir Crit Care Med; 1997 Apr; 155(4):1316-22. PubMed ID: 9105073
[TBL] [Abstract][Full Text] [Related]
3. Effects of NCPAP therapy on fibrinogen levels in obstructive sleep apnea syndrome.
Chin K; Ohi M; Kita H; Noguchi T; Otsuka N; Tsuboi T; Mishima M; Kuno K
Am J Respir Crit Care Med; 1996 Jun; 153(6 Pt 1):1972-6. PubMed ID: 8665063
[TBL] [Abstract][Full Text] [Related]
4. The nocturnal secretion of cardiac natriuretic peptides during obstructive sleep apnoea and its response to therapy with nasal continuous positive airway pressure.
Kita H; Ohi M; Chin K; Noguchi T; Otsuka N; Tsuboi T; Itoh H; Nakao K; Kuno K
J Sleep Res; 1998 Sep; 7(3):199-207. PubMed ID: 9785275
[TBL] [Abstract][Full Text] [Related]
5. Prescription of nCPAP and nBIPAP in obstructive sleep apnoea syndrome: Italian experience in 105 subjects. A prospective two centre study.
Resta O; Guido P; Picca V; Sabato R; Rizzi M; Scarpelli F; Sergi M
Respir Med; 1998 Jun; 92(6):820-7. PubMed ID: 9850365
[TBL] [Abstract][Full Text] [Related]
6. nCPAP treatment interruption in OSA patients.
Fiz JA; Abad J; Ruiz J; Riera M; Izquierdo J; Morera J
Respir Med; 1998 Jan; 92(1):28-31. PubMed ID: 9519221
[TBL] [Abstract][Full Text] [Related]
7. Improvement of factor VII clotting activity following long-term NCPAP treatment in obstructive sleep apnoea syndrome.
Chin K; Kita H; Noguchi T; Otsuka N; Tsuboi T; Nakamura T; Shimizu K; Mishima M; Ohi M
QJM; 1998 Sep; 91(9):627-33. PubMed ID: 10024917
[TBL] [Abstract][Full Text] [Related]
8. Abnormal autonomic stress responses in obstructive sleep apnoea are reversed by nasal continuous positive airway pressure.
Veale D; Pépin JL; Wuyam B; Lévy PA
Eur Respir J; 1996 Oct; 9(10):2122-6. PubMed ID: 8902477
[TBL] [Abstract][Full Text] [Related]
9. Residual effect of nCPAP applied for part of the night in patients with obstructive sleep apnoea.
Hers V; Liistro G; Dury M; Collard P; Aubert G; Rodenstein DO
Eur Respir J; 1997 May; 10(5):973-6. PubMed ID: 9163633
[TBL] [Abstract][Full Text] [Related]
10. Nasal continuous positive airway pressure with supplemental oxygen in coexistent sleep apnoea-hypopnoea syndrome and severe chronic obstructive pulmonary disease.
Sampol G; Sagalés MT; Roca A; de la Calzada MD; Bofill JM; Morell F
Eur Respir J; 1996 Jan; 9(1):111-6. PubMed ID: 8834343
[TBL] [Abstract][Full Text] [Related]
11. Pituitary reactivity, androgens and catecholamines in obstructive sleep apnoea. Effects of continuous positive airway pressure treatment (CPAP).
Bratel T; Wennlund A; Carlström K
Respir Med; 1999 Jan; 93(1):1-7. PubMed ID: 10464840
[TBL] [Abstract][Full Text] [Related]
12. Blood pressure, catecholamines, and pancreatic polypeptide in obstructive sleep apnea with and without nasal Continuous Positive Airway Pressure (nCPAP) treatment.
Jennum P; Wildschiødtz G; Christensen NJ; Schwartz T
Am J Hypertens; 1989 Nov; 2(11 Pt 1):847-52. PubMed ID: 2686712
[TBL] [Abstract][Full Text] [Related]
13. Changes in the arterial PCO2 during a single night's sleep in patients with obstructive sleep apnea.
Chin K; Hirai M; Kuriyama T; Fukui M; Kuno K; Sagawa Y; Ohi M
Intern Med; 1997 Jul; 36(7):454-60. PubMed ID: 9240492
[TBL] [Abstract][Full Text] [Related]
14. Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy.
Chin K; Shimizu K; Nakamura T; Narai N; Masuzaki H; Ogawa Y; Mishima M; Nakamura T; Nakao K; Ohi M
Circulation; 1999 Aug; 100(7):706-12. PubMed ID: 10449691
[TBL] [Abstract][Full Text] [Related]
15. Nasopharyngeal symptoms and nasal continuous positive airway pressure therapy in obstructive sleep apnoea syndrome.
Lojander J; Brander PE; Ammälä K
Acta Otolaryngol; 1999; 119(4):497-502. PubMed ID: 10445068
[TBL] [Abstract][Full Text] [Related]
16. [Therapy with nasal CPAP (continuous positive airway pressure) in patients with obstructive sleep apnea syndrome (OSAS). I: Long-term acceptance of nasal CPAP].
Hollandt JH; Kuhl S; Siegert R
Laryngorhinootologie; 1997 Sep; 76(9):550-3. PubMed ID: 9417184
[TBL] [Abstract][Full Text] [Related]
17. Effect of nasal CPAP on ventilatory drive in normocapnic and hypercapnic patients with obstructive sleep apnoea syndrome.
Lin CC
Eur Respir J; 1994 Nov; 7(11):2005-10. PubMed ID: 7875273
[TBL] [Abstract][Full Text] [Related]
18. [Predictive factors of minimally effective nCPAP ventilation in treatment of obstructive sleep apnea?].
Teschler H; Hoheisel G; Wagner B; Schumann H; Konietzko N
Med Klin (Munich); 1995 Jun; 90(6):330-7. PubMed ID: 7637664
[TBL] [Abstract][Full Text] [Related]
19. Impact of nasal continuous positive airway pressure treatment on quality of life in patients with obstructive sleep apnoea.
Bolitschek J; Schmeiser-Rieder A; Schobersberger R; Rosenberger A; Kunze M; Aigner K
Eur Respir J; 1998 Apr; 11(4):890-4. PubMed ID: 9623693
[TBL] [Abstract][Full Text] [Related]
20. Cerebral hemodynamic changes in sleep apnea syndrome and effect of continuous positive airway pressure treatment.
Diomedi M; Placidi F; Cupini LM; Bernardi G; Silvestrini M
Neurology; 1998 Oct; 51(4):1051-6. PubMed ID: 9781528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
